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Functional MRI neurofeedback (NF) allows humans to self-modulate neural patterns in specific brain 
areas. This technique is regarded as a promising tool to translate neuroscientific knowledge into 
brain-guided psychiatric interventions. However, its clinical implementation is restricted by 
unstandardized methodological practices, by clinical definitions that are poorly grounded in 
neurobiology, and by lack of a unifying framework that dictates experimental choices. Here we put 
forward a new framework, termed ‘process-based NF’, which endorses a process-oriented 
characterization of mental dysfunctions to form precise and effective psychiatric treatments. This 
framework relies on targeting specific dysfunctional mental processes by modifying their underlying 
neural mechanisms and on applying process-specific contextual feedback interfaces. Finally, 
process-based NF offers designs and a control condition that address the methodological 
shortcomings of current approaches, thus paving the way for a precise and personalized 
neuromodulation. 
 
The use of functional MRI (fMRI) in neurofeedback (fMRI-NF) has brought new hope to the field of 
self-guided neuromodulation. fMRI-NF allows individuals to modulate spatially localized neural 
patterns in real-time, using contingent rewarding feedback. Accumulating evidence suggests that in 
many cases, attaining significant neural modulations in line with the task protocol (i.e., NF success) is 
followed by corresponding mental and behavioural changes1, thus contributing to bridging the gap 
between brain functionality and our mental experience. Despite this promising prospect, the 
utilization of fMRI-NF for basic science as well as for clinical purposes has been slower than expected. 
This may be due to various methodological constraints, such as the lack of proper control conditions 
and inadequate blinding and randomization, as well as the relatively small sample sizes that 
characterize the field. Furthermore, brain-guided interventions do not correspond with current 
psychiatric categorization, which traditionally relies on subjective reports rather than on 
neurobehavioral substrates2,3. Together, these limitations have hampered tangible conclusions 
regarding the clinical relevance and efficacy of fMRI-NF4–6. 
 
It is generally acknowledged that, to improve precision and efficacy of psychiatric treatments, new 
insights regarding the psychological and neural substrates of maladaptive behaviours should be 
incorporated into the conceptualization of mental disorders7,8. Such insights imply that the brain is 
functionally organized around several neural circuits that subserve perception, motivation, cognition, 
emotion, and social behavior9–12. In line with this, we put forward a new framework termed ‘process-
based NF’, which suggests that NF interventions should target specific dysfunctional mental processes 
by modifying their underlying neural mechanisms (Fig. 1a–c). 
 
A crucial organizing principle in process-based NF is that a correspondence should be established 
between different aspects of the intervention (neural target, feedback interface, outcome measures, 
and study population) and a specific, functionally defined mental process targeted for modulation, 
which in turn should generate exact, evidence-based predictions of clinical efficacy. This principle of 
correspondence and its benefits can be exemplified with the case of NF treatment for major 
depressive disorder (MDD). In common practice, the main outcome measure for MDD treatments is 
symptom severity (for example, Dekte et al.13 and the Hypericum depression trial study group14). 
However, MDD is in fact a clinical syndrome comprised of various distinct groups of symptoms, 
including mood and motivational dysfunctions (for example, anhedonia), cognitive rumination, 
anxiety, and abnormal sleep patterns15. Importantly, each of these classes of symptoms is associated 
with a distinct mental process and its associated neural mechanism16.By targeting an impaired mental 
process, such as deficient approach motivation (which is thought to underlie anhedonia), rather than 
overall depression severity, it is possible to match the intervention’s neural target for modulation—
for example, certain features of the extensively investigated mesolimbic reward system11,17,18— 
with specific hedonic outcome measures. For the latter, one could apply a subjective report 
questionnaire of hedonic experience (for example, the Snaith–Hamilton Pleasure Scale19) and 
objective measures of responsivity to reward (for example, the monetary incentive delay task20), both 
known to be specifically mediated by the targeted mesolimbic circuit21,22. Furthermore, for the sake 
of clinical precision, a process-based approach also calls for a shift in the current focus from 
supposedly pure diagnostic Diagnostic and Statistical Manual15 or International Classification of 
Diseases23 grouping criteria. For instance, when targeting deficient approach motivation, a clinical 
study could include MDD patients that specifically suffer from anhedonia, as well as individuals 
without a formal diagnosis of MDD who nevertheless exhibit substantial hedonic deficits, such as 
patients with Parkinson disease, substance use disorders, or schizophrenia24–26.  
 
In this Perspective, we attempt to delineate the process-based approach for NF by associating it with 
various central aspects of the intervention. We begin by addressing the manner in which psychological 
processes and their underlying neural mechanisms may be ideally targeted and modulated. Following 
this, we discuss possible ways to optimize process targeting via feedback interface adjustments. 
Finally, we discuss the NF general processes and offer possible designs and a new control condition 
for dissociating between NF-general task effects and those specific to the targeted process 
modulations. We assert that by applying such process specific modifications, the NF field could offer 
a brain-guided psychiatric intervention with greater scientific validity and enhanced efficacy. 
 
  
 
Fig. 1 | Process-based NF framework. Three principal elements of process-based NF interventions: 
functional process and neural target selection; feedback interface; and outcome measures. a, Three 
functional processes, associated with three distinct neural targets (represented schematically): 
cognitive control (blue), approach motivation (green), and potential threat (brown). Varying greyscale 
intensities indicate differential involvement of each process in three Diagnostic and Statistical Manual 
categorical disorders: substance use disorder (SUD), MDD, and specific phobia. b, Feedback interfaces 
adapted to correspond with the targeted process, via process-specific multimodal stimuli. In the 
illustrated example, a participant is navigating a supermarket scenario in VR. For cognitive control 
deficit in the context of SUD, feedback is displayed through addiction-related appetitive cues that 
change in size in proportion to modulation of cognitive control network activity. For deficient 
approach motivation in MDD, a rewarding smiling face of a sales assistant alters in proportion to 
modulation of the reward mesolimbic circuit neural activity. For potential threat dysfunction in 
specific phobia, a phobia-related cue changes in size in proportion to modulation of the threat neural 
circuit activity. c, Subjective and objective outcome measures that correspond with the targeted 
process. For cognitive control deficit, the Conners impulsivity scale and a go/no-go task. For deficient 
approach motivation, the Snaith–Hamilton 
Scale (SHAPS) is used to measure hedonic experience and reward responsivity is measured by the 
monetary incentive delay task. For potential threat, the subjective unit for distress scale and the no 
shock–predictable shock–unpredictable shock (NPU) task are used. 
 
In this Perspective, we attempt to delineate the process-based approach for NF by associating it with 
various central aspects of the intervention. We begin by addressing the manner in which psychological 
processes and their underlying neural mechanisms may be ideally targeted and modulated. Following 
this, we discuss possible ways to optimize process targeting via feedback interface adjustments. 
Finally, we discuss the NF general processes and offer possible designs and a new control condition 
for dissociating between NF-general task effects and those specific to the targeted process 
modulations. We assert that by applying such process specific modifications, the NF field could offer 
a brain-guided psychiatric intervention with greater scientific validity and enhanced efficacy. 
 
Process-based neural targeting 
Accumulating evidence from human neuroimaging studies suggests that psychiatric disorders share 
common trans-diagnostic structural and functional impairments in neural networks9,27–29. In 
accordance with this notion, a substantial body of work has demonstrated that network-level 
patterns, rather than focal neural patterns, encode core mental processes. For instance, emotion 
regulation is thought to be characterized by interplay between core limbic or salience circuits and 
regulatory prefrontal sets of regions30, rather than by isolated amygdala or prefrontal cortex (PFC) 
activity. Likewise, inhibitory control, a dysfunctional process in attention deficit hyperactivity 
disorder31 and substance use disorder32, was suggested to be linked with a set of frontoparietal 
networks rather than with a specific brain area such as the inferior frontal gyrus33. Moreover, recent 
works using multivariate analyses have shown that subjective experiences and mental states that 
relate to various pathological conditions are associated with distributed neural activations. This was 
recently demonstrated in pain34,35, sustained attention36, and negative affect37. It follows that the 
dysfunctions of neuropsychological processes in psychiatric syndromes are mediated by distributed, 
network-level abnormalities, rather than focal impairments9. 
 
Interestingly, network-level functional changes were shown to occur following single-region fMRI-NF. 
For example, several studies have demonstrated that PFC and amygdala connectivity was altered 
following amygdala downregulation NF38–40. Likewise, Cohen- Kadosh et al.41 found that insula 
fMRI-NF subsequently resulted in functional connectivity changes in an emotion-regulation network. 
These results indicate that regulation of a single region, based on the classic univariate analysis of 
blood-oxygen level dependent (BOLD) activity, may conjointly lead to a distributed neural change. 
Hence the clinical efficacy of fMRI-NF interventions targeting single regions may result from 
widespread network-level changes (for example, connectivity of the regulated region with other 
regions or networks), rather than from restricted alterations in the targeted region of interest. 
Considering these points, we posit that NF interventions should target brain networks (i.e., activity or 
connectivity indices) or distributed patterns that specifically mediate dysfunctional processes, as 
outlined below. 
 
Brain network matrices. Various NF targets have been previously applied to modulate network-level 
functionality, such as functional connectivity between two or more brain regions42–45, as well as 
more complex network dynamics indices (for example, dynamic causal modelling NF46,47). For 
instance, Yamada et al. attempted to alter dysfunctional hyper-connected patterns of the default-
mode and frontoparietal networks by training participants to decrease functional connectivity 
between the posterior cingulate cortex and dorsolateral PFC, two respective key hubs of these 
networks44. Such practice resulted in a decrease in depressive symptoms, as measured with the 
Hamilton Depression Rating Scale, which was correlated with NF success. A different network-NF 
approach was recently developed by Jacob et al.48, which trained participants to modify a central 
region’s influence on an entire functional network. Results demonstrated the feasibility of facilitating 
changes in network functional hierarchy via NF training. 
 
Another method that efficiently measures the neural substrates of mental processes is multivariate 
or multivoxel pattern analysis (MVPA). MVPA captures neural information that is distributed over 
many voxels or regions in the brain. It has been used extensively in the attempt to decode mental 
states from brain activation49,50, and more recently it has been implemented in real-time imaging51 
and specifically in NF (in decoded neurofeedback, DecNef)52,53. Key assumptions of DecNef are that 
neural patterns that are congruent with a mental state can be manipulated and that the endogenous 
modulation of a mental state should lead to corresponding mental and behavioural changes. Hence 
this method may serve as a good surrogate for process-based NF (for a detailed review on DecNef 
applications see refs. 44,54). So far, DecNef has been applied to induce perceptual53, cognitive55, and 
affective modifications56 in healthy individuals. More recently, this concept was clinically applied to 
individuals suffering from specific phobia57. In this study, a neurotypical activity pattern in the ventral 
temporal area was first calculated based on data from healthy individuals that were exposed to 
aversive stimuli, representing adaptive emotional processing. Subsequently, participants diagnosed 
with specific phobia, exhibiting atypical responses to aversive stimuli, were trained to modulate their 
ventral temporal activity to resemble the predefined neurotypical voxel-wise pattern. Notably, this 
was achieved via an implicit learning procedure, associating desired changes in activity with positive 
reward cues, without exposing the patients to the object of their phobia.  
 
Notwithstanding the above, process-based neural targeting may present several challenges. First, it is 
noteworthy that regulating complex distributed indices requires high signal reliability. To this end, 
using functional localizer tasks to better target individual network nodes (possibly in combination with 
predefined anatomical or meta-analytic derived masks) could improve precision of network indices 
and consequently enhance signal reliability. In the case of dynamic causal modelling-based NF, 
sufficiently long time windows should be used for the assessments of the different models, to enable 
precise feedback regarding network causal relationships. Such requirement might be met via 
intermittent feedback protocols. Another issue revolves around the scalability of the process-based 
intervention. fMRI holds a critical advantage over other recoding techniques for targeting defined 
neural mechanisms: its superior spatial resolution. Yet its limited accessibility might hamper fMRINF 
clinical translation. Electroencephalograms (EEG), on the other hand, are cost-effective and mobile. 
However, due to poor spatial resolution, EEG’s ability to target functional processes associated with 
distributed cortical as well as subcortical areas is severely limited. Hence a measuring tool that offers 
both precise localization and high accessibility is greatly needed for the applicability of process-based 
NF (Box 1). Another issue that arises when targeting processes for modulation is the consideration of 
subjects’ developmental stage58,59, i.e., whether one should attempt to modulate brain regions 
associated with a cognitive process at the specific developmental stage or simply target the brain 
networks associated with a given process in healthy mature adults. This is especially important if one 
considers the developing brain as an adaptive system, in which brain networks that support cognitive 
abilities change interactively as a result of ongoing brain maturation and cognitive development60,61. 
Finally, although theoretical considerations suggest the superiority of network-based or distributed-
pattern-based NF over single-region NF interventions, it is yet to be established that such indices may 
indeed lead to improved NF modulations and enhanced clinical outcomes. Future studies should thus 
compare between network NF and single-region NF in terms of modulation success and clinical 
benefits. 
 
 
 
 
Process-based feedback interfaces 
The feedback interface forms the environmental setting of the intervention. To date, the majority of 
NF studies have used simple forms of interfaces solely to indicate the level of neural activity change 
(for example, thermometer62,63, a visual analogue scale64,65, or sound66,67). These interfaces are 
usually one-dimensional (size or height; volume or pitch), unimodal (visual or auditory), and affectively 
neutral. Therefore, they hardly evoke a specific process by themselves. In contrast, process-specific 
adjustment of the feedback interface can considerably contribute to the targeting of dysfunctional 
processes in two ways: (i) by inducing an environmental context in which deficits are typically 
expressed, individuals may be guided to practice process-relevant strategies in situations similar to 
those they naturally struggle with, but in a safe and controlled clinical setting; and (ii) as the underlying 
neural mechanisms one is trying to alter are dysfunctional, provoking them in a process-specific 
manner might assist in recruiting them and thus promote the desired neurobehavioral changes. 
Consequently, process targeting may become more precise, ecological, and clinically effective. In an 
attempt to promote such an approach, we discuss possible modes of context induction: the 
incorporation of multimodal contextual cues into the interface and the utilization of immersive 
feedback interfaces (Fig. 1b). 
 
Contextual interfaces. Several NF studies have incorporated process-specific contextual cues into a 
neutral feedback interface, creating an emotional context for affective processes38,68–70. Paret et 
al.69 trained healthy participants to downregulate their amygdala, a region involved in emotion 
processing and regulation, while viewing aversive photos with a thermometer indicating the level of 
neural activity from both sides of the image. Participants successfully regulated amygdala activity, and 
furthermore, NF success was correlated with post-practice amygdala regulation with no feedback (i.e., 
transfer effects, which indicate the generalization of acquired regulation skills). In two clinical studies, 
patients with borderline personality disorder and post-traumatic stress disorder (PTSD)39,40 
practiced amygdala downregulation while watching affective stimuli (pictures with affectively 
disturbing content or trauma-related words, respectively). Both groups exhibited widely distributed 
neural 
changes along with reduced dissociative symptoms. 
 
Other than using process-specific contextual cues along with a neutral feedback display (for example, 
a thermometer), the feedback itself could represent the neural changes in a processspecific manner. 
For example, Sokunbi et al.71 and Ihssen et al.72 employed ‘motivational feedback’ interfaces, in 
which participants are presented with reward-related stimuli (for example, appetizing food) that 
change in size in proportion to BOLD fluctuations in regions involved in motivational aspects of craving. 
Hence the attempt to up- or downregulate neural activity in itself facilitates process-specific 
motivational consequences. A similar approach might be taken with an ‘emotional feedback’ 
interface. 
Even though evidence of efficacy is still scarce, we can cautiously assume that if the undesired patterns 
of an affective neural target were represented by an aversive emotional feedback, participants may 
be specifically motivated to downregulate it. This might be true not only due to contextual affective 
induction, but also as successful regulation results in attenuation of the aversive feedback. 
Furthermore, since affective interfaces may facilitate a stressful or 
unpleasant context that resembles process-relevant real-life situations, the acquired neural regulation 
skills may therefore be better generalized. Conversely, one could argue that such approach might 
encourage maladaptive avoidance tendencies that are inherent to 
the psychopathology, as is the case in obsessive–compulsive disorder and PTSD. A possible solution 
for this issue could be altering the content of the stimuli rather than its size or simulated distance from 
the trainee. For instance, in the case of motivational feedback 
for substance use disorder, alcoholic beverages could be gradually replaced with soft drinks. 
 
Importantly, both modes of context induction are particularly relevant for the modulation of neural 
‘hubs’ that underlie several processes (for example, insula, amygdala, etc.). For instance, Young et 
al.73 employed a hedonic-related context (via instructions: retrieving positive memories) to guide 
amygdala upregulation for MDD patients with hedonic deficits. Alternatively, by incorporating 
negative affective stimuli cues into the interface, the amygdala was targeted for downregulation both 
for PTSD40 and borderline personality disorder39 
patients. Further research should try to reveal in which cases could neural hubs that are involved in 
several processes be provoked in a process-specific manner via different types of context induction. 
Aside from contextualizing the feedback interface, other feedback interface factors may be harnessed 
for process induction. These include the utilization of different feedback protocols for process 
targeting (Box 2) as well as NF task instructions (i.e., providing participants with suggestions for specific 
process-related imageries)74,75. 
 
Immersive interfaces. Recent applications in the rapidly evolving fields of VR and augmented reality 
(AR) may be used to simulate highly naturalistic environments enriched with process-relevant cues. 
Unlike the common one-dimensional and unimodal feedback, three-dimensional game-like interfaces 
enable presentations of multimodal dynamic stimuli76 that may improve learning and user 
experience77. Cohen et al. directly compared a unimodal thermometer with a multimodal game-like 
NF interface and showed that the latter indeed resulted in improved learning, generalizability, and 
user experience78. Mathiak et al. compared simple visual feedback (a bar) with VR-based social 
reward feedback (a smile on an avatar face that is altered as a function of dorsal anterior cingulate 
cortex BOLD activity); results demonstrated that the VR interface induced increased target 
engagement and promoted learning79. Notably, immersive VR and AR environments allow substantial 
flexibility in context representation80, which may be highly beneficial in certain cases. For instance, 
people suffering from dysfunctions in threat processing (for example, social anxiety disorders, PTSD, 
etc.) could be trained by associating their experienced virtual environment with their neural state, 
such that gaining control over threat-related neural targets would result in a more tranquil simulated 
environment that corresponds with their specific phobia (social- or trauma-related, etc.). This could 
further strengthen adaptive behaviours, for example, approach towards phobia-related cues (Fig. 1b). 
Such applications correspond with the growing practice in psychiatry of applying VR environments in 
exposure procedures, mainly for the treatment of PTSD and phobias81–83. Several studies have used 
VR or AR to create process-specific contexts in the treatment of psychiatric and neurologic 
disorders84–86, demonstrating the feasibility of applying such therapeutic interventions. Yet these 
studies serve as small-scale proofs-of-concept that rely on EEG frequency bands with poor localization. 
Hence further research is needed to realize the full clinical potential and efficacy of VR and AR 
technologies for NF training in general and within the process-based framework specifically.  
 
Process-based NF specificity  
To determine NF treatment specificity, the effects resulting from modulation of a specific target 
process must be differentiated from those of mere NF practice. To this end, five types of control 
conditions have been applied thus far: (i) alternative NF, providing feedback from an alternative 
region; (ii) inverse NF, modulation of the experimental neural target in the opposite direction; (iii) 
yoked sham NF, presenting participants with sham feedback recorded from a matched subject from 
the experimental group; (iv) mental rehearsal, applying mental strategies with no feedback 
presentation; and (v) no treatment, a natural history control condition4. We note that there is a 
tendency to evaluate novel interventions such as NF according to the experimental standards of 
pharmacological randomized controlled trials. However, this is misleading, as pharmacotherapeutic 
placebo interventions affect only the underlying mechanisms of non-specific affective processes, 
generally in the same manner as the real drug87. Active NF control conditions, on the other hand, 
manipulate sensory, cognitive, and affective aspects that may introduce two main classes of 
confounds: (i) modulations of additional processes that are not engaged in the experimental 
intervention and (ii) modulations of NF-general processes that substantially vary from the 
experimental intervention. To eliminate these confounds, NF control conditions must involve the 
same general processes modulations as those of the experimental condition, without any additional 
processes engagements (Fig. 2). 
 
 
 
Converging evidence from various animal and human studies46,82,83,88 indicate that fMRI-NF 
involves three general processes1: (i) control: applying different mental strategies in the 
attempt to modulate the presented feedback, associated with the lateral occipital cortex, posterior 
cingulate cortex, and dorsolateral PFC; (ii) reward: valuation of positive or negative outcomes of 
applied strategies, associated with anterior cingulate cortex, anterior insula, and ventral striatum; and 
(iii) learning: the consolidation of associations between rewarding feedback cues and a desired neural 
activity pattern (or specific mental imageries), which may occur through operant learning mechanisms 
that involve the dorsal striatum. A recent meta-analysis by Emmert et al.89 revealed a network of 
regions activated during NF practice regardless of a specific neural target, composed mainly of 
prefrontal, mesolimbic, and striatal regions. This network corresponds with the underlying 
mechanisms of NF-general processes mentioned above and may be considered a general network of 
fMRI-NF. However, studies investigating NF general processes are still scarce and have yet to resolve 
disagreements between different NF learning models (for example, skill learning versus operant 
learning; see ref. 1). Notably, Paret et al.90 employed amygdala fMRI-NF and succeeded in dissociating 
feedback congruency monitoring (i.e., tracking feedback correspondence with task instructions; 
associated with the ventral striatum), feedback context monitoring (i.e., responses to differing task 
instructions; associated with rostral PFC), feedback activity monitoring (i.e., general feedback 
fluctuations; associated with thalamus and ventromedial PFC), and other task-related activations 
(including insula, anterior cingulate, and lateral PFC), thus providing a more intricate map of NF 
underlying mechanisms. Importantly, different NF protocols (Box 2) vary in their manipulations of the 
general task processes. These differences could be capitalized to investigate the NF underlying 
mechanisms and to advance a more precise understanding as to which of the NF general processes 
hold unique contribution in terms of modulation success and clinical benefits. Figure 3a presents two 
protocols that may be used to isolate reward and control processes. NF learning, however, presents a 
more complex challenge, as multiple learning processes may co-occur during NF1. One design that 
may unravel the involvement of stimulus–response contingencies in NF learning (the stimulus being 
the contingent feedback and the response being the neural target activations) could be an implicit NF 
design that excludes the voluntary use of regulation strategies, in which stimulus–response 
contingencies are varied between conditions via differential feedback timing protocols: a continuous 
condition, an intermediate intermittent condition (in which feedback is presented once every few 
functional time points), and a fully intermittent condition. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Dissociating NF-general from target processes. As Fig. 2 shows, confounds of both NF-general and 
additional processes are particularly relevant to inverse NF and alternative NF. First, these control 
conditions involve not only NF-general processes but also an additional target process that is not 
manipulated in the experimental condition. Second, some targets are inherently harder to modulate 
than others91, as has been shown to occur in many cases90,92–94. Differences in ‘modulability’ 
between experimental and control neural targets incur discrepancies in task difficulty and, as a result, 
in the level of reward participants receive. An indication of both confounds has been recently shown 
by Alegria et al94. This study controlled for right inferior frontal gyrus fMRI-NF intervention for 
attention deficit–hyperactivity disorder patients, with alternative NF to the left parahippocampal 
cortex. Specifically, this alternative NF group exhibited increased activations in bilateral 
parahippocampal cortex, right supplementary motor area, and additional frontotemporal regions 
involved in various motor and cognitive functions95–97, which were not activated in the right inferior 
frontal gyrus NF group. Moreover, substantial differences between conditions were exhibited both in 
the absolute value of NF success (the level of positive feedback differed between groups) and in 
transfer effects, possibly leading to confounds of reward processes. Consequently, treatment efficacy 
cannot be specifically attributed to the target process engagement with such control groups. 
 
In contrast, yoked sham NF only manipulates NF-general processes, but in a different manner than the 
experimental condition. First, the lack of contingency between feedback and neural patterns could 
lead to major differences in NF reward processes, as participants may deduce they are not receiving 
veritable feedback98 and thus may reduce their motivation, task engagement, and positive 
expectations in relation to a genuine feedback group. Second, even when matching feedback 
variability between groups by ‘yoking’ in a double-blinded manner, there would still exist differences 
in NF learning, as no learning based on contingencies between neural patterns and feedback would 
occur. Corresponding to this last confound are the models of NF learning that stress the importance 
of associative (i.e., Hebbian) learning mechanisms that rely on contingencies between stimulus and 
response. Thus, yoked-sham NF also cannot isolate the hypothesized factor. 
 
Finally, mental rehearsal control does not tease apart the specific effects of the neural target 
modulations, but rather the additive value of the interface and feedback presentation themselves. 
A no-treatment control may be useful for determining whether there are clinical effects that justify 
further investigations, but it does not isolate any non-specific effects. 
 
On top of these condition-specific confounds, two general confounds may occur that could possibly 
be dealt with. First, it is known that subjects vary in their ability to regulate brain activation. These 
individual differences in NF learning capabilities may be predicted via behavioural99, 
functional100,101, or anatomical102,103 indices and therefore should be taken into consideration 
when allocating participants to study groups. Second, a unique methodological issue arises when 
specifically targeting the NF-general processes for modulation (for example, reward93,104,105 and 
control94,106,107). Such targets are even more problematic to control for, as they are recruited by 
the mere performance of a NF task, with every possible matched control involving the target process 
(for a possible solution, see Fig. 3a). 
 
Hence it appears that each of the four common NF control conditions 
consist of process engagements that do not allow for the disentanglement of target from NF-general 
effects. An ideal control condition requires a genuine NF intervention that manipulates the same 
general processes, but without any specific modulations over and above the general NF processes (Fig. 
2). In line with the processbased framework, we suggest a control condition that should produce such 
a psychophysiological state, termed ‘randomized region of interest (ROI) NF’ (Fig. 3b). In a randomized 
ROI NF group, participants would be randomly allocated to one of several subgroups of different target 
processes. The resulting group, matched in numbers of participants to the experimental group, would 
have participants modulating the NF-general processes with authentic feedback, just as in the 
experimental group, but with the specific effects of the different neural targets averaged out across 
all subgroups, as each would receive a different neural target to regulate. 
 
 
 
 
 
This may lead to the cancelling-out of confounds related to additional processes modulations. 
Nonetheless, the same reward-related modulability confound that affects alternative NF and inverse 
NFshould apply here. However, in randomized ROI NF, this confound is moderated by the same 
concept of averaging out varying task effects between subgroups. While each subgroup may differ in 
its reward modulations, the overall group reward modulations should average to the mean level of all 
selected targets. It follows that differences in reward modulations between an experimental target 
NF and a randomized ROI NF group would be restricted to the difference from a mean reward 
modulation value, corresponding to the mean level of task difficulty. This contrasts with alternative 
and inverse NF that may coincidently produce large and unaccounted-for reward-related differences, 
as shown above. Hence given no prior knowledge on targets modulability, randomized ROI NF should 
yield a preferable psychophysiological state in terms of general NF processes modulations. 
 
Moreover, future methodological studies could provide essential information on NF targets 
modulability in two ways: one, different neural targets may be directly compared to one another, as 
has been recently demonstrated for NF to visual areas91; second, modulability of different neural 
targets could be inspected in a meta-analysis or a critical review, by assessing NF success across all 
applied neural targets in fMRI-NF studies, thus composing a ‘modulability index’ for NF targets (Fig. 
3b). Such studies should enable informed target selection in the future, such that control targets could 
resemble the experimental target in their level of modulability, thereby further minimizing reward-
related confounds, for randomized ROI NF as well as for alternative NF control condition. 
 
Finally, it is advisable to avoid major differences in the complexity of the interfaces employed to 
accommodate each randomized ROI NF subgroup and the interface used by the experimental group. 
To achieve this without forfeiting process specificity, one could induce process-specific contexts via 
simple contextual interface, similarto the one employed by Paret et al.69. For example, subgroups for 
neural targets of emotion regulation, approach motivation, and potential threat could be 
contextualized via aversive, appetitive, and threatrelated stimuli, respectively, changing only the 
content of the pictures with all other interface features remaining constant. Alternatively, one could 
establish a modular immersive scenario (Fig. 1b) that can differentially accommodate several 
functional processes. 
 
Consequently, a randomized ROI NF control group should differ from an experimental NF group only 
in the lack of a specific target process. Therefore, it should enable dissociation between target process 
effects and NF general effects, supporting a more concise conclusion regarding treatment specificity 
of NF interventions, using only two study groups. 
 
Conclusions and future avenues of research 
In the current perspective, we presented a new framework for NF, termed process-based NF. This 
framework suggests that NF interventions should target dysfunctional processes with defined neural 
substrates rather than clusters of symptoms, thus adopting a dimensional approach toward mental 
disorders. Accordingly, the different aspects of the intervention (neural target selection, feedback 
interface, and clinical outcome measures) should correspond with the target process 
to optimally ameliorate dysfunctions. Specifically, we suggest that process targeting could be 
maximized by relying on current neuroscientific theoretical and practical knowledge regarding the 
neural substrates of functional processes, moving beyond single-region NF toward alterations in 
network activity and connectivity patterns. We further suggest the development of process-specific 
interfaces with contextual cues and the enhancement of process engagement via immersive VR 
and/or AR technologies. Additionally, we show that a process-based approach allows a more precise 
methodology for determining the specificity of NF effects. To that end, we propose several 
methodological designs and a new control condition that may enable the disentanglement of general 
from target-specific effects, an unresolved issue in current NF methodology. Some current 
developments that are discussed above, such as dynamic causal modelling NF, DecNef, and simple 
contextual feedback interfaces are initial instances that relate to the processbased NF approach, each 
dealing with separate aspects of NF. Our outlined framework integrates these developments into a 
unifying schema that provides a clear rationale for the construction of all critical stages of NF 
interventions. The framework further prescribes other suggestions, such as the utilization of 
immersive VR and AR technologies for process targeting and the process-based application of EFP 
models for improved accessibility, as well as the use of different feedback protocols and a new control 
condition for determining specificity. These new propositions, however, have yet 
to be fully developed and validated. Thus, future interventional NF studies that adopt the proposed 
framework may enhance our knowledge of the efficacy of NF across neuropsychological domains and 
diagnostic groups and may further refine the framework’s features. Importantly, the process-based 
framework calls for many modifications; however, it is not mandatory to bind them together. 
Researchers who wish to enhance NF efficacy or to better determine specificity may adopt some 
suggestions while passing over other advocated guidelines. Nonetheless, based on the considerations 
in this paper, we would argue that a process-based approach that harmonizes neural targets, feedback 
interfaces, and outcome measures is crucial for the further development of NF into a scientifically 
precise and clinically applicable neuromodulation tool. 
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